FDA Commissioner Resignation Opens Path to Banning Mail-Order Abortion Drugs

The resignation of FDA Commissioner Dr. Marty Makary creates a strategic opportunity for the agency to return to its mission of protecting public safety by banning dangerous mail-order abortion drugs. This development is significant for those advocating for the protection of unborn life and the regulation of pharmaceutical distribution. It represents a potential shift in federal policy that could impact access to abortion pills across the United States.